Qisheng Li, M.D., Ph.D.
Dr. Li received clinical training first as a medical student at the Second Military Medical University in Shanghai, China, and then as a Physician in Hepatology at the university's affiliated Shanghai Changzheng Hospital. He received basic research training in molecular and cell biology and virology at Nanyang Technological University in Singapore, where he obtained his Ph.D. in 2007. From 2006 to 2007, he was a Senior Fellow at the University of Washington Medical Center in Seattle, conducting clinical research on HCV/HIV co-infection cohorts with Dr. David R. Gretch. Dr. Li was a Postdoctoral and then Research Fellow at the Liver Diseases Branch of NIDDK, NIH with Dr. T. Jake Liang from 2007 to 2013. He is now a Staff Scientist at the Liver Diseases and Virology Section, and his current research is focused on identifying novel host pathways and disease mechanisms by which HCV infects hepatocytes and causes progressive liver damage applying integrative functional genomics and systems biology approaches, and translating the findings to host-dependency drug discovery paradigm to optimize the treatment regimen of hepatitis C and associated chronic liver diseases.